CSL · 10 hours ago
Senior Director, Regional Ecosystem Lead (US Westcoast)
CSL is a biotech company focused on delivering impactful therapies for patients. They are seeking a Senior Director, Regional Ecosystem Lead to enhance their brand and pipeline by engaging with innovation hubs and building strategic relationships within the biotech ecosystem.
Responsibilities
Serve as the key CSL leader within the regional innovation ecosystem, actively sourcing opportunities aligned with all TA strategies and portfolio priorities. Create new partnership opportunities for GLG presence within each ecosystem
Maintain and expand strategic relationships with universities, incubators, accelerators, venture capital firms, and local organizations to amplify CSL’s external innovation priorities
Partner closely with TA Search Leads to conduct regional searches, plan engagements and conferences, and share regional insights and updates
Serve as a senior member of deal teams occurring in each region, supporting transactions from identification through due diligence and help lead relationships with external partners through deal close
Organize and represent CSL at local external innovation events, such as CSL-hosted innovation days, and ensure strong visibility in the ecosystem
Actively participate as a board member in key industry bodies and associations (e.g., MassBio, AusBiotech, Californai Bio, etc.) and pursue board or committee memberships to influence industry direction and strengthen networks
Maintain intimate knowledge of internal organizational capabilities, priorities, and SMEs and engage internal experts to enhance credibility and reputation externally
Provide insights on regional biotech trends, competitive landscape, and innovation hotspots
Work closely with R&D; BD, and legal teams to evaluate and integrate external assets
Qualification
Required
12+ years in biopharma, external innovation, or business development with strong regional network and ecosystem knowledge
Advanced degree required (PhD, MD, or equivalent)
Proven track record of enhancing Pharma senior leadership presence/reputation as a partner of choice in biotech ecosystems to drive BD deal flow
Proven ability to source and evaluate external opportunities and lead deal execution
Strong relationship-building skills with academic, biotech, and investment communities
Benefits
Incentive compensation
Equity
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase